Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Kucheryavyy, Yury A.
17  Ergebnisse:
Personensuche X
?
1

Therapeutic efficacy evaluation of the reference drug ursod..:

Kucheryavyy, Yury A. ; Cheremushkin, Sergei V.
Consilium Medicum.  24 (2023)  12 - p. 860-864 , 2023
Link: https://doi.org/10.26442..
 
?
2

Prevalence of non-alcoholic fat disease liver in Russian Fe..:

Maev, Igor V. ; Andreev, Dmitry N. ; Kucheryavyy, Yury A.
Consilium Medicum.  25 (2023)  5 - p. 313-319 , 2023
Link: https://doi.org/10.26442..
 
?
3

Metabolically associated fatty liver disease – a disease of..:

Maev, Igor V. ; Andreev, Dmitry N. ; Kucheryavyy, Yury A.
Consilium Medicum.  24 (2022)  5 - p. 325-332 , 2022
Link: https://doi.org/10.26442..
 
?
4

Prevention and treatment of some gastrointestinal complicat..:

Ilchishina, Tatiana A. ; Kucheryavyy, Yury A. ; Sviridova, Tatiana N.
Consilium Medicum.  24 (2022)  5 - p. 312-316 , 2022
Link: https://doi.org/10.26442..
 
?
5

Exocrine pancreas insufficiency: clinical significance and ..:

Maev, Igor V. ; Kucheryavyy, Yury A. ; Andreev, Dmitry N.
Terapevticheskii arkhiv.  93 (2021)  4 - p. 509-515 , 2021
Link: https://doi.org/10.26442..
 
?
6

Author's Reply to Petersen: "Differences in In Vitro Proper..:

Maev, Igor V. ; Kucheryavyy, Yury A. ; Gubergrits, Natalya B....
Drugs in R&D.  21 (2021)  4 - p. 469-470 , 2021
Link: https://doi.org/10.1007/..
 
?
7

Obesity as a risk factor for diseases of the digestive syst..:

Andreev, Dmitry N. ; Kucheryavyy, Yury A.
Terapevticheskii arkhiv.  93 (2021)  8 - p. 954-962 , 2021
Link: https://doi.org/10.26442..
 
?
8

Differences in In Vitro Properties of Pancreatin Preparatio..:

Maev, Igor V. ; Kucheryavyy, Yury A. ; Gubergrits, Natalya B....
Drugs in R&D.  20 (2020)  4 - p. 369-376 , 2020
Link: https://doi.org/10.1007/..
 
?
9

Author's Reply to Petersen: "Differences in In Vitro Proper..:

Maev, Igor V ; Kucheryavyy, Yury A ; Gubergrits, Natalya B...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602466/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
10

Differences in In Vitro Properties of Pancreatin Preparatio..:

Maev, Igor V ; Kucheryavyy, Yury A ; Gubergrits, Natalya B...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7691409/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
11

Therapeutic efficacy evaluation of the reference drug ursod..:

Yury A. Kucheryavyy ; Sergei V. Cheremushkin
https://consilium.orscience.ru/2075-1753/article/viewFile/111183/85627.  , 2023
Link: https://doi.org/10.26442..
 
?
12

Prevalence of non-alcoholic fat disease liver in Russian Fe..:

Igor V. Maev ; Dmitry N. Andreev ; Yury A. Kucheryavyy
https://consilium.orscience.ru/2075-1753/article/viewFile/567841/133268.  , 2023
Link: https://doi.org/10.26442..
 
?
13

Metabolically associated fatty liver disease – a disease of..:

Igor V. Maev ; Dmitry N. Andreev ; Yury A. Kucheryavyy
https://consilium.orscience.ru/2075-1753/article/viewFile/112444/87265.  , 2022
Link: https://doi.org/10.26442..
 
?
14

Prevention and treatment of some gastrointestinal complicat..:

Tatiana A. Ilchishina ; Yury A. Kucheryavyy ; Tatiana N. Sviridova
https://consilium.orscience.ru/2075-1753/article/viewFile/112442/87263.  , 2022
Link: https://doi.org/10.26442..
 
?
15

Exocrine pancreas insufficiency: clinical significance and ..:

Igor V. Maev ; Yury A. Kucheryavyy ; Dmitry N. Andreev
https://ter-arkhiv.ru/0040-3660/article/viewFile/71269/52041.  , 2021
Link: https://doi.org/10.26442..
 
1-15